S. Chang et al., Use of indapamide in hospital and community clinics and its effect on plasma potassium in Chinese patients, J CLIN PH T, 23(4), 1998, pp. 295-302
Objectives: To investigate the usage pattern of indapamide and other antihy
pertensive drugs in patients attending a community-based government outpati
ent clinic (GOPC) or a hospital-based specialist clinic (SC). The plasma po
tassium concentrations of patients receiving indapamide and other diuretics
were also examined.
Method: Prescriptions from the SC and the GOPC were reviewed and collected
during January 1998. Patients' plasma potassium concentrations and the date
of initiation of each medication were retrieved from the hospital computer
databases at SC. An age- and sex-matched control group of patients on non-
diuretic antihypertensive drugs was identified.
Results: A total of 1648 and 773 prescriptions were collected from the SC d
uring a 1-week period and GOPC during a I-month period, respectively. Appro
ximately half (45%) of the patients received antihypertensive treatment. In
dapamide was five times more frequently prescribed in GOPC than SC (84.7 vs
. 17.7%, P<0.001). Calcium channel blocking agents were the commonest antih
ypertensive drugs used in both clinics. The mean plasma potassium concentra
tion of patients taking indapamide was lower than that of the control group
(P=0.037). Multiple linear regression analysis showed that consumption of
indapamide (P=0.002) and duration of diuretic therapy (P=0.023) were signif
icantly related to changes in plasma potassium concentrations [multiple reg
ression equation for potassium level= 4.09-0.145 (thiazide=1)-0.377 (indapa
mide=1) - 0.00468 (duration of diuretic therapy in months)].
Conclusion: Indapamide was used extensively in the community clinic and les
s in the hospital-based outpatient clinic. Patients receiving indapamide ha
d a significantly lower plasma potassium concentration as compared to other
diuretics or antihypertensive groups and this was predicted by a multiple
linear regression model. Monitoring plasma electrolytes before initiation o
f indapamide treatment and at regular intervals thereafter is essential for
detecting the hypokalaemia that may occur in Chinese patients.